Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace

NCT05110872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2025-10-07

Study results available
· View outcomes & findings →

Summary

This is a one-session study that participants complete remotely including consent, Experimental Tobacco Marketplace purchases, and assessments to examine the effects of cigarette and e-cigarette flavors on cigarette demand and substitution in the Experimental Tobacco Marketplace.

Conditions

  • Tobacco Use Disorder

Interventions

BEHAVIORAL

Cigarette flavor restricted and e-cigarette flavor restricted

1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace 2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

BEHAVIORAL

Cigarette flavor restricted and e-cigarette flavor unrestricted

1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace 2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

BEHAVIORAL

Cigarette flavor unrestricted and e-cigarette flavor restricted

1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace 2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

BEHAVIORAL

Cigarette flavor unrestricted and e-cigarette flavor unrestricted

1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace 2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Sponsors & Collaborators

  • University of Minnesota

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • Virginia Polytechnic Institute and State University

    lead OTHER

Principal Investigators

  • Warren K Bickel, Ph.D. · Fralin Biomedical Research Institute at VTC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-26
Primary Completion
2021-08-13
Completion
2021-08-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05110872 on ClinicalTrials.gov